Astera Labs (NASDAQ:ALAB) Stock Gets Price Target Trim from TD Cowen

Astera Labs (NASDAQ:ALAB) had its target price lowered by TD Cowen from $300.00 to $225.00 in a research note released on Wednesday morning,Benzinga reports. The firm currently has a hold rating on the stock.

Other research analysts have also recently issued research reports about the company. Royal Bank Of Canada decreased their price target on Astera Labs from $500.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday. Barclays increased their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Weiss Ratings lowered Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research report on Friday, October 23rd. Finally, Jefferies Financial Group upped their target price on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Thirteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $320.85.

Astera Labs Stock Performance

Shares of ALAB traded up $11.24 on Wednesday, hitting $190.71. 6,642,738 shares of the stock traded hands, compared to its average volume of 4,244,483. The company has a market capitalization of $33.09 billion, a PE ratio of 75.98 and a beta of 3.85. The business has a 50 day simple moving average of $300.46 and a 200 day simple moving average of $255.80. Astera Labs has a one year low of $97.89 and a one year high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.13. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The business had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. During the same period in the prior year, the firm posted $0.49 EPS. The firm’s quarterly revenue was up 153.6% on a year-over-year basis. On average, equities analysts expect that Astera Labs will post 2.71 earnings per share for the current year.

Insider Activity

In related news, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total value of $3,382,283.64. Following the sale, the director owned 2,648 shares of the company’s stock, valued at approximately $995,806.88. This trade represents a 77.25% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 396,059 shares of company stock worth $123,408,470. Insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of large investors have recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Astera Labs during the 2nd quarter valued at about $6,609,581,000. Bank of America Corp DE purchased a new position in shares of Astera Labs in the second quarter worth approximately $1,061,791,000. Atreides Management LP grew its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares during the period. Amundi grew its position in Astera Labs by 77.9% during the first quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after buying an additional 823,477 shares during the period. Finally, Deutsche Bank AG bought a new stake in Astera Labs during the second quarter valued at approximately $325,602,000. 60.47% of the stock is currently owned by institutional investors.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported Q3 revenue of $584.9 million, up 154% year over year, and its Scorpio switch business was highlighted as a major growth driver. One Seeking Alpha contributor upgraded the stock, citing Scorpio’s momentum and gross margins that may stabilize near 72%. Astera Labs: So Much To Like In Q3 (Upgrade)
• Positive Sentiment: BMO Capital initiated coverage with an Outperform rating and a $375 price target; Northland Securities also upgraded the stock to Outperform. These calls provide a counterpoint to recent selling and valuation worries. BMO Capital Initiates Coverage on Astera Labs With Outperform Rating Astera Labs Upgraded to Outperform at Northland Securities
• Neutral Sentiment: Analyst views remain divided, with one recent opinion arguing that the selloff may already reflect a potential growth slowdown in 2027. Astera Labs: Sell-Off Already Priced In 2027 Stall
• Negative Sentiment: A reported analyst downgrade triggered renewed pressure, while coverage also points to ALAB’s rich valuation after its Q3 results. Those concerns may amplify selling when technology stocks are broadly weak. Shares Gap Down After Analyst Downgrade Stock Drops After Q3 Results Spotlight Rich Valuation
• Negative Sentiment: Astera Labs was caught in a wider technology-sector selloff, adding market-wide pressure beyond company-specific news. Astera Labs Falls Amid Tech Selloff

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.